Search results
22 kwi 2024 · In 2022, PWID accounted for 7% (2,300) of the 31,800 estimated new HIV infections. Men who inject drugs accounted for 4% (1,300) of estimated new HIV infections. Women who inject drugs accounted for 3% (1,000) of estimated new HIV infections. Estimated HIV infections among people who inject drugs in the US.
21 maj 2024 · This page provides an overview of estimates of HIV incidence (number of new HIV infections), prevalence (persons living with diagnosed or undiagnosed HIV infection), and percentage of diagnosed infections among persons living with HIV (knowledge of status) in the United States.
The tables in this guideline (for each vaccine listed) present the recommended immunizations for adults with HIV, followed by discussion of each. For complete vaccination recommendations, see the CDC Immunization Schedules and the vaccine manufacturers’ package inserts.
15 sie 2024 · In 2022, an estimated 31,800 people acquired HIV in the U.S. Estimated new HIV infections decreased 12% from 36,300 in 2018 to 31,800 in 2022. In 2022, 37,981 people aged ≥ 13 and older received an HIV diagnosis in the U.S. and 6 territories and freely associated states.
We analysed publicly available HIV surveillance data and census data to describe: current HIV prevalence and new HIV diagnoses by region, race or ethnicity, and age; trends in HIV diagnoses over time by HIV acquisition risk and age; and the distribution of HIV prevalence by geographical area.
30 lis 2021 · Over the course of the last three decades, over 2.2 million people have been diagnosed and reported with HIV in the WHO European Region, including over 560 000 people in the EU/EEA. In 2020, 104 765 people were newly diagnosed with HIV.
27 paź 2020 · The first HIV vaccine trial carried out in the US investigated a recombinant envelope glycoprotein (rgpl60), VaxSyn, created in a baculovirus-insect cell system. This trial evaluated the safety and immunogenicity of a rgpl60 candidate vaccine in 72 healthy, HIV-negative adults.
